Nasdaq

nasdaqA Major Shareholder Wants to Take This Fitness Franchisor Private

Six months of strategic review silence. Now Fund 1 Investments is offering $5.61 to $7.00 a share in cash — at least 50% above where the stock sat a day earlier.

A Major Shareholder Wants to Take This Fitness Franchisor Private
Illustration: markets sector, not the company's own operations. Financial District, Manhattan skylines in 2012 — Yair-haklai, CC BY-SA 4.0, via Wikimedia Commons.

Six months ago, Xponential Fitness opened a review of strategic alternatives, including a potential sale or merger. Independent directors led the process; Jefferies advised. No outcome was announced. On October 30, one large shareholder stopped waiting.

Xponential Fitness, Inc. NYSE: XPOF

Fund 1 Investments delivered a letter to the board that day proposing a cash take-private at between $5.61 and $7.00 per share. Fund 1 says that range is at least 50% above the October 29 close of $3.74. The offer is non-binding and subject to board approval, due diligence and financing — though Fund 1 says any final deal would carry no financing condition.

For a shareholder watching the review drag on, the proposal puts a stated cash range on the table, and it comes from a holder that is heavily exposed to the outcome. Fund 1 holds about 4.2 million shares at roughly 9.9% direct ownership, plus cash-settled swaps referencing a similar number of notional shares, for total economic exposure of about 19.9% of the outstanding Class A stock. That is not a position someone walks away from cheaply.

The timing tells its own story. When Xponential announced the strategic review on April 6, 2026, the stock stood at $6.76. By October 29 it had fallen to $3.74. The Fund 1 letter says shareholders have suffered a further decline while the review produced no public result. The offer is partly a bid and partly a verdict on the process.

There is one complication. Xponential adopted a stockholder rights plan — the kind of defence that limits how much any one investor can accumulate — on October 12, 2026, eighteen days before Fund 1's letter arrived. Fund 1 says it would ask the board to waive that plan so it can bring in co-investors alongside it. Whether the board grants one will say a great deal about how seriously it is taking the offer.

Shares closed 19.25% higher at $4.46 after the filing, on dollar volume of about $8.2 million across about 13,900 trades.

Fund 1 filed the letter as a Schedule 13D amendment, making it visible to every shareholder. The company now has a specific price range in front of it, a bidder holding a fifth of the economic interest, and shareholders who can see exactly what is on offer.

Written by the PennyStocks.News desk from company filings and releases. Figures as reported by the company; no guarantee of accuracy or completeness. Nothing here is investment advice.